[go: up one dir, main page]

NO20054728L - Preparat for administrering av jern for behandling av rastlose ben syndrom - Google Patents

Preparat for administrering av jern for behandling av rastlose ben syndrom

Info

Publication number
NO20054728L
NO20054728L NO20054728A NO20054728A NO20054728L NO 20054728 L NO20054728 L NO 20054728L NO 20054728 A NO20054728 A NO 20054728A NO 20054728 A NO20054728 A NO 20054728A NO 20054728 L NO20054728 L NO 20054728L
Authority
NO
Norway
Prior art keywords
iron
administration
preparation
treatment
restless leg
Prior art date
Application number
NO20054728A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054728D0 (no
Inventor
Mary Jane Helenek
Ralf A Lange
Fred B Oldham
Marc L Tokars
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of NO20054728D0 publication Critical patent/NO20054728D0/no
Publication of NO20054728L publication Critical patent/NO20054728L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20054728A 2003-03-14 2005-10-13 Preparat for administrering av jern for behandling av rastlose ben syndrom NO20054728L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/389,228 US6960571B2 (en) 2003-03-14 2003-03-14 Methods and compositions for administration of iron for the treatment of restless leg syndrome
PCT/US2003/015087 WO2004082693A1 (fr) 2003-03-14 2003-05-13 Composition pour l'administration de fer traitant le syndrome des jambes sans repos

Publications (2)

Publication Number Publication Date
NO20054728D0 NO20054728D0 (no) 2005-10-13
NO20054728L true NO20054728L (no) 2005-12-13

Family

ID=32962229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054728A NO20054728L (no) 2003-03-14 2005-10-13 Preparat for administrering av jern for behandling av rastlose ben syndrom

Country Status (25)

Country Link
US (1) US6960571B2 (fr)
EP (1) EP1603580B1 (fr)
JP (2) JP2006520322A (fr)
KR (1) KR100978377B1 (fr)
CN (1) CN1771044B (fr)
AT (1) ATE400280T1 (fr)
AU (1) AU2003249635C1 (fr)
BR (1) BR0318185A (fr)
CA (1) CA2518971C (fr)
CY (1) CY1110407T1 (fr)
DE (1) DE60322121D1 (fr)
DK (1) DK1603580T3 (fr)
ES (1) ES2309403T3 (fr)
HR (1) HRP20050796A2 (fr)
IL (1) IL170386A (fr)
MX (1) MXPA05009786A (fr)
NO (1) NO20054728L (fr)
PL (1) PL206810B1 (fr)
PT (1) PT1603580E (fr)
RS (1) RS51823B (fr)
RU (1) RU2319490C2 (fr)
SI (1) SI1603580T1 (fr)
UA (1) UA83483C2 (fr)
WO (1) WO2004082693A1 (fr)
ZA (1) ZA200508308B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1655040A1 (fr) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Formulations comprenant des agent de contrast pour la visualisation du systeme lymphatique
EP1790356A1 (fr) * 2005-11-24 2007-05-30 Vifor (International) Ag Préparation contenant des complexes de fer(III) et des composés rédoxs
US20090304816A1 (en) * 2005-12-20 2009-12-10 Cereuscience Ab Method and composition for treating and diagnosing restless legs syndrome
CN101384295B (zh) * 2005-12-23 2014-10-29 阿贾伊·古普塔 含铁的肠胃外营养组合物
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
KR20140117678A (ko) 2006-01-06 2014-10-07 루이트폴드 파머수티컬스, 인코퍼레이티드 철을 투여하기 위한 방법 및 조성물
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
EP1941869A1 (fr) * 2007-01-04 2008-07-09 Vifor (International) Ag Sachet à plusieurs compartiments pour stocker de préparations de fer
BRPI0822397A2 (pt) * 2008-03-28 2014-10-07 Chyna Llc Uso de ferritina para tratar transtornos de deficiência de ferro
EP2296998A1 (fr) * 2008-05-23 2011-03-23 Hospira, Inc. Produits conditionnés fer-sucrose
BRPI0921431A2 (pt) * 2008-11-06 2017-06-06 Biotie Therapies Ag método para tratar ou prevenir síndrome das pernas inquietas, composição farmacêutica, e, métodos para tratar ou prevenir distúrbios do sono, e para melhorar a quantidade do sono ou adequação do sono
AU2009342799B2 (en) 2009-03-25 2014-12-18 Pharmacosmos Holding A/S A stable iron oligosaccharide compound
US8058076B2 (en) * 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN102440999A (zh) * 2010-10-15 2012-05-09 天津瑞普生物技术股份有限公司 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物
WO2012104204A1 (fr) 2011-01-31 2012-08-09 Vifor (International) Ag Composés à base d'un complexe de fer-hydrate de carbone pour la thérapie intraveineuse du paludisme
AU2014236677B2 (en) 2013-03-15 2018-07-05 Intrinsic Lifesciences Llc Anti-hepcidin antibodies and uses thereof
JP2014132029A (ja) * 2014-04-03 2014-07-17 Chyna Llc 鉄欠乏性障害を治療するためのフェリチンの使用
NZ730186A (en) 2014-09-22 2020-04-24 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
WO2016069950A2 (fr) * 2014-10-29 2016-05-06 University Of Utah Research Foundation Méthodes de traitement d'affections optiques associées à l'hypoxie à l'aide d'une protéine matricielle oligomérique du cartilage-angiopoïétine 1 (comp-ang1)
EP2913054A1 (fr) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Hydrate de carbone de fer complexe pour le traitement du syndrome des jambes sans repos (sjsr)
CN118103047A (zh) 2021-08-27 2024-05-28 美国瑞根特有限公司 铁组合物及其制备和使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248492A (en) * 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5700832A (en) * 1994-10-19 1997-12-23 Daewon Pharm. Co., Ltd. Antianemic agent containing iron and difructose
RU2153351C2 (ru) * 1995-12-14 2000-07-27 Закрытое акционерное общество "ВАМ" Средство для регулирования эндогенной продукции цитокинов и гемопоэтических факторов (варианты) и способ его использования
SE9803760D0 (sv) 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
WO2001074162A1 (fr) 2000-04-04 2001-10-11 The Regents Of The University Of California Traitement des troubles du sommeil par l'hypocretine 1

Also Published As

Publication number Publication date
DE60322121D1 (de) 2008-08-21
EP1603580A1 (fr) 2005-12-14
HRP20050796A2 (en) 2005-12-31
BR0318185A (pt) 2006-03-21
CA2518971A1 (fr) 2004-09-30
CA2518971C (fr) 2009-02-17
KR100978377B1 (ko) 2010-08-30
RU2319490C2 (ru) 2008-03-20
AU2003249635B2 (en) 2009-06-04
PT1603580E (pt) 2008-09-10
AU2003249635A1 (en) 2004-10-11
JP2010180252A (ja) 2010-08-19
NO20054728D0 (no) 2005-10-13
CN1771044A (zh) 2006-05-10
CY1110407T1 (el) 2015-04-29
RU2005131832A (ru) 2006-03-20
EP1603580B1 (fr) 2008-07-09
CN1771044B (zh) 2012-09-19
US20040180849A1 (en) 2004-09-16
MXPA05009786A (es) 2006-03-08
HK1089666A1 (en) 2006-12-08
ES2309403T3 (es) 2008-12-16
JP2006520322A (ja) 2006-09-07
RS20050695A (sr) 2008-04-04
DK1603580T3 (da) 2008-10-06
RS51823B (sr) 2012-02-29
KR20060082032A (ko) 2006-07-14
PL206810B1 (pl) 2010-09-30
ATE400280T1 (de) 2008-07-15
ZA200508308B (en) 2006-10-25
UA83483C2 (uk) 2008-07-25
PL378875A1 (pl) 2006-05-29
US6960571B2 (en) 2005-11-01
AU2003249635C1 (en) 2009-11-05
WO2004082693A1 (fr) 2004-09-30
IL170386A (en) 2013-03-24
SI1603580T1 (sl) 2009-04-30

Similar Documents

Publication Publication Date Title
NO20054728L (no) Preparat for administrering av jern for behandling av rastlose ben syndrom
BRPI0507984A (pt) composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamìfero, para melhorar a resistência de insulina em um mamìfero e para prevenir ou tratar doenças circulatórias em um mamìfero, e, uso do composto
EP1670450A4 (fr) Compositions pharmaceutiques et procede d'utilisation de la levodopa et de la carbidopa
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MY132789A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
NO20070113L (no) Opioider for behandling av restless legs syndromet
NO20045240L (no) Transepikutan administrasjonsform for a behandle restless legs syndromet
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
IL164195A0 (en) Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
WO2007055804A3 (fr) Methodes et compositions permettant l'administration de fer pour le traitement du syndrome des jambes sans repos
PL1648473T3 (pl) Pojedyncza dawka szybko rozpuszczającej się azytromycyny
MXPA05013901A (es) Uso de acido alfa-cetoglutarico para tratamiento de desnutricion o condicion de glucosa alta en plasma.
ATE395936T1 (de) Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten
TW200514582A (en) Transdermal preparation and method for reducing side effect in pergolide therapy
PL372313A1 (en) Method for producing pseudo islets
SE0301947D0 (sv) New method and uses
FR2860234B1 (fr) Nouveaux derives 666 du thioxylose
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
EA200400817A1 (ru) Идрапаринукс для лечения и вторичной профилактики случаев венозной тромбоэмболии у пациентов с тромбозом глубоких вен

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application